T cells from complete-responding patients with CLL after receiving CD19-directed CAR-Ts were enriched in memory-related genes, whereas T cells from non-responders demonstrated upregulation of effector differentiation programs. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.